Coral Laboratories [CORALAB] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
Coral Laboratories
BSE
Loading...
Divi's Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Coral Laboratories wins in 5 metrics, Divi's Laboratories wins in 15 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Coral Laboratories | Divi's Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 7.14 | 70.79 | Coral Laboratories |
| Price-to-Book Ratio | 0.86 | 10.93 | Coral Laboratories |
| Debt-to-Equity Ratio | 1.77 | 0.03 | Divi's Laboratories |
| PEG Ratio | 8.30 | 2.67 | Divi's Laboratories |
| EV/EBITDA | 3.87 | 51.97 | Coral Laboratories |
| Profit Margin (TTM) | 17.54% | 23.89% | Divi's Laboratories |
| Operating Margin (TTM) | 9.19% | 25.60% | Divi's Laboratories |
| EBITDA Margin (TTM) | 9.19% | 25.60% | Divi's Laboratories |
| Return on Equity | 12.01% | 14.64% | Divi's Laboratories |
| Return on Assets (TTM) | 10.53% | 12.94% | Divi's Laboratories |
| Free Cash Flow (TTM) | $-41.67M | $2.15B | Divi's Laboratories |
| Dividend Yield | 0.34% | 0.91% | Divi's Laboratories |
| 1-Year Return | -46.90% | 25.20% | Divi's Laboratories |
| Price-to-Sales Ratio (TTM) | 1.69 | 16.95 | Coral Laboratories |
| Enterprise Value | $685.43M | $1,592.76B | Divi's Laboratories |
| EV/Revenue Ratio | 0.67 | 16.50 | Coral Laboratories |
| Gross Profit Margin (TTM) | 48.21% | 60.33% | Divi's Laboratories |
| Revenue per Share (TTM) | $286 | $363 | Divi's Laboratories |
| Earnings per Share (Diluted) | $67.61 | $87.08 | Divi's Laboratories |
| Beta (Stock Volatility) | 0.68 | 0.27 | Divi's Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Coral Laboratories vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Coral Laboratories | -0.56% | -13.11% | -17.08% | -34.91% | -38.74% | -40.76% |
| Divi's Laboratories | -1.26% | 1.99% | -9.10% | -7.61% | 2.44% | 0.11% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Coral Laboratories | -46.90% | 89.29% | 59.31% | -5.81% | 363.91% | 383.43% |
| Divi's Laboratories | 25.20% | 69.46% | 85.76% | 440.94% | 1,532.61% | 8,233.79% |
Performance & Financial Health Analysis: Coral Laboratories vs Divi's Laboratories
| Metric | CORALAB | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.72B | ₹1.64T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 2,320 | 557,925 |
| 90 Day Avg. Volume | 1,350 | 372,093 |
| Last Close | ₹480.00 | ₹6,005.00 |
| 52 Week Range | ₹471.00 - ₹999.00 | ₹4,663.30 - ₹7,071.50 |
| % from 52W High | -51.95% | -15.08% |
| All-Time High | ₹1,190.00 (Jul 24, 2017) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -59.66% | -15.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.41% | 0.14% |
| Quarterly Earnings Growth | -0.71% | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.24% |
| Operating Margin (TTM) | 0.09% | 0.26% |
| Return on Equity (TTM) | 0.12% | 0.15% |
| Debt to Equity (MRQ) | 1.77 | 0.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹562.96 | ₹563.87 |
| Cash per Share (MRQ) | ₹300.75 | ₹132.86 |
| Operating Cash Flow (TTM) | ₹106.44M | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹241.56M | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.34% | 0.91% |
| Last 12-Month Dividend | ₹2.00 | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Coral Laboratories vs Divi's Laboratories
| Metric | CORALAB | DIVISLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 7.14 | 70.79 |
| Forward P/E | 8.30 | 109.49 |
| PEG Ratio | 8.30 | 2.67 |
| Price to Sales (TTM) | 1.69 | 16.95 |
| Price to Book (MRQ) | 0.86 | 10.93 |
| Market Capitalization | ||
| Market Capitalization | ₹1.72B | ₹1.64T |
| Enterprise Value | ₹685.43M | ₹1.59T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.67 | 16.50 |
| Enterprise to EBITDA | 3.87 | 51.97 |
| Risk & Other Metrics | ||
| Beta | 0.68 | 0.27 |
| Book Value per Share (MRQ) | ₹562.96 | ₹563.87 |
Financial Statements Comparison: Coral Laboratories vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CORALAB | DIVISLAB |
|---|---|---|
| Revenue/Sales | ₹281.35M | ₹24.10B |
| Cost of Goods Sold | ₹145.71M | ₹9.56B |
| Gross Profit | ₹135.64M | ₹14.54B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹21.79M | ₹6.17B |
| EBITDA | ₹51.66M | ₹8.48B |
| Pre-Tax Income | ₹38.52M | ₹7.33B |
| Income Tax | ₹10.25M | ₹1.88B |
| Net Income (Profit) | ₹28.27M | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CORALAB | DIVISLAB |
|---|---|---|
| Cash & Equivalents | ₹34.06M | ₹4.15B |
| Total Current Assets | ₹1.77B | ₹100.81B |
| Total Current Liabilities | ₹249.58M | ₹14.52B |
| Long-Term Debt | ₹0 | ₹20.00M |
| Total Shareholders Equity | ₹2.01B | ₹149.69B |
| Retained Earnings | N/A | ₹134.00B |
| Property, Plant & Equipment | ₹217.44M | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CORALAB | DIVISLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CORALAB | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 2,320 | 557,925 |
| Average Daily Volume (90 Day) | 1,350 | 372,093 |
| Shares Outstanding | 3.57M | 265.47M |
| Float Shares | 806,826 | 120.74M |
| % Held by Insiders | 0.78% | 0.52% |
| % Held by Institutions | 0.00% | 0.29% |
Dividend Analysis & Yield Comparison: Coral Laboratories vs Divi's Laboratories
| Metric | CORALAB | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | ₹60.00 |
| Last 12-Month Dividend Yield | 0.34% | 0.91% |
| 3-Year Avg Annual Dividend | ₹0.67 | ₹50.00 |
| 3-Year Avg Dividend Yield | 0.22% | 0.70% |
| 3-Year Total Dividends | ₹2.00 | ₹150.00 |
| Ex-Dividend Date | Sep 20, 2024 | Jul 25, 2025 |